Edition:
United States

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

4.15USD
17 Aug 2018
Change (% chg)

$-0.05 (-1.19%)
Prev Close
$4.20
Open
$4.15
Day's High
$4.20
Day's Low
$4.05
Volume
96,536
Avg. Vol
103,770
52-wk High
$18.15
52-wk Low
$4.05

Chart for

About

Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide therapeutic solutions. The Company’s lead product is Baxdela, an antibiotic approved by the United States food and drug administration (FDA) for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). The... (more)

Overall

Beta: 1.21
Market Cap(Mil.): $221.48
Shares Outstanding(Mil.): 53.37
Dividend: --
Yield (%): --

Financials

  MLNT.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -6.95 -- --
ROI: -37.42 2.89 12.63
ROE: -62.04 1.65 14.82

BRIEF-Melinta Therapeutics Prices Public Offering Of 22.0 Mln Shares At $5/Share

* MELINTA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

May 23 2018

BRIEF-Melinta Therapeutics Announces Proposed Offering Of Common Stock

* MELINTA THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

May 21 2018

BRIEF-Melinta Therapeutics Q1 Loss Per Share $0.95

* MELINTA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 08 2018

BRIEF-Melinta Therapeutics Q4 Loss Per Share $1.48

* MELINTA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 13 2018

BRIEF-Melinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application For Delafloxacin In Europe

* MELINTA THERAPEUTICS PARTNER, MENARINI GROUP, SUBMITS MARKETING AUTHORIZATION APPLICATION FOR DELAFLOXACIN IN EUROPE

Mar 08 2018

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,882 +25.00
Johnson & Johnson (JNJ.N) $134.47 +1.99
Pfizer Inc. (PFE.N) $42.09 +0.67
Roche Holding Ltd. (ROG.S) CHF239.95 +0.75
Roche Holding Ltd. (RO.S) CHF243.20 +0.20
Abbott Laboratories (ABT.N) $64.72 +0.56
Bayer AG (BAYGn.DE) €78.40 +1.35
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.30 +0.64
AstraZeneca plc (AZN.L) 5,930.00 -6.00

Earnings vs. Estimates